0
0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Pacira BioSciences Inc

    Pacira BioSciences Inc (Pacira), formerly Pacira Pharmaceuticals Inc, provides non-opioid pain management and regenerative health solutions. The company develops drugs based on its proprietary DepoFoam drug delivery technology. Its lead product candidate, Exparel (bupivacaine liposome injectable suspension) is an amide-type local anesthetic administered at the time of surgery to control pain and eliminate the use of opioids for acute postsurgical pain. Its other products include iovera, a non-opioid treatment intended to block pain, and relieve pain and symptoms related to...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Harvard Bioscience Inc

    Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets instruments, consumables, systems and software. The company’s products include spectrophotometers, plate readers, gel electrophoresis equipment, amino acid analyzers, electroporation and electrofusion instruments, wireless monitors, data acquisition and analysis products and software, and syringe pump and peristaltic pumps, among others. It also provides data analysis, training and installation services. Harvard Bioscience serves research scientists at pharmaceutical and biotechnology companies, hospitals, universities, government laboratories, and contract research organizations. It markets products directly in...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Coherus BioSciences Inc

    Coherus BioSciences Inc (Coherus) is a biopharmaceutical company that conducts research, development and commercialization of immunotherapies to treat cancer. The company markets Udenyca (pegfilgrastim-cbqv), a biosimilar of Neulasta, and Cimerli (ranibizumab-eqrn), a biosimilar of Lucentis, in the US. Coherus products find its application for the treatment of various therapeutic areas which includes nasopharyngeal carcinoma, hepatocellular carcinoma, non-small lung cancer, small cell lung cancer and solid tumors. It is evaluating Toripalimab’s pivotal clinical trial for the treatment of nasopharyngeal carcinoma. The...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Genocea Biosciences, Inc.

    Genocea Biosciences Inc (Genocea), formerly Genocea Inc is a biopharmaceutical company. It develops targeted vaccines and immunotherapies for the treatment of cancer. The company’s pipeline products include Gen-009 and Gen-010, a neoantigen cancer vaccine; Gen-011 is an adoptive T cell therapy. It utilizes ATLAS technology platform that identify immunotherapy targets based on tumor antigen-specific T cell responses. The company develops neoantigen cancer vaccines, general cancer vaccines, and a vaccine targeting cancers caused by epstein-barr virus using its technology platform. Genocea...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Caladrius Biosciences Inc

    Lisata Therapeutics Inc (Lisata Therapeutics), formerly Caladrius Biosciences Inc, is a biopharmaceutical company. It discovers and develops cellular therapies for the treatment of cardiovascular indications and autoimmune diseases. It is investigating XOWNA for the treatment of coronary microvascular dysfunction; HONEDRA against critical limb ischemia and buerger’s disease. The company is also evaluating CLBS201 for the treatment of diabetic kidney disease (DKD); and CLBS14 to treat no-option refractory disabling angina. Lisata Therapeutics utilizes its proprietary CD34+ cell therapy technology to develop...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Aytu BioScience Inc

    Aytu BioPharma Inc (Ayut BioPharma) is a specialty pharmaceutical company that offers prescription therapeutics and consumer health products. Its key prescription products treat attention deficit hyperactivity disorder (ADHD) and other common pediatric conditions. The company markets ADHD products under Adzenys XR-ODT (amphetamine) and Cotempla XR-ODT brands. It also markets ZolpiMist, a short-term treatment for insomnia characterized by difficulties with sleep initiation, Karbinal ER (carbinoxamine maleate), an extended-release carbinoxamine suspension to treat numerous allergic conditions, and Tri-Vi-Flor and Poly-Vi-Flor, two complementary...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Cellectar Biosciences Inc

    Cellectar Biosciences Inc (Cellectar), is a biopharmaceutical company that discovers, develops and commercializes drugs for treatment of cancer. The company’s proprietary technology, phospholipid drug conjugates (PDC) delivery platform develops PDCs for the treatment and diagnosis of cancer. Its lead product includes CLR 131, is a small-molecule PDC, in Phase II clinical trials for the treatment of relapse or refractory multiple myeloma and B-cell lymphomas. The company is also evaluating CLR 131 in Phase I clinical trials for treatment of Pediatric...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Assembly Biosciences Inc

    Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium difficile (C. difficile) infections (CDI) and chronic hepatitis B virus (HBV). It also develops Gemicel platform technology that helps for targeted oral delivery vaccines, small molecules, live biotherapeutics, and complex macromolecules that are aimed for specific region in gastrointestinal tract (GI). Assembly's HBV Cure...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Twist Bioscience Corp

    Twist Bioscience Corp (Twist Bioscience) is a synthetic biology company that carries out the development of synthetic DNA and synthetic DNA-based products. The company offers synthetic genes and gene fragments, oligonucleotide, IgG proteins, next-generation sequencing (NGS) tools, drug and target discovery solutions, and synthetic viral controls, infectious disease research tools. Its products are used to treat influenzas, rhinoviruses, respiratory syncytial virus, SARS, MERS and coronaviruses, among others. Twist Bioscience’s silicon-based DNA synthesis platform enables the sequencing process and the production...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Selecta Biosciences Inc

    Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302, and SEL-302. It utilizes synthetic vaccine particle (SVP) technology platform to incorporate a wide range of antigens and immunomodulators, for the development of products that induce antigen-specific tolerance or activate the immune system. Selecta Biosciences develops products for the treatment of infections, central nervous system diseases, cancer, allergies, cardiovascular diseases,...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.